1 terminated. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Terminated 1 |
Follow balixafortide: new trials by email Literature Review of balixafortide trials Research Report on balixafortide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pivotal Study in HER2 Negative, Locally Recurrent or Metastatic Breast Cancer Eribulin, Balixafortide - Metastatic Breast Cancer, Locally Recurrent Breast Cancer | Phase 3 | Terminated | Spexis AG | 432 | 2019-05-30 | 2023-11-01 |
Breast Neoplasms (1)
Spexis AG (1)
Argentina (1) · Belgium (1) · Brazil (1) · Czechia (1) · France (1) · Italy (1) · Russia (1) · South Korea (1) · Spain (1) · Taiwan (1) · Ukraine (1) · United Kingdom (1) · United States (1)
Javier Cortes, MD (1) · Peter A Kaufman, MD (1)